Sensorion Will Present Two Posters at the Association for Research in Otolaryngology ARO 46th Annual MidWinter Meeting

Regulatory News: Sensorion (FR0012596468 ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the

Related Keywords

Florida ,United States ,Orlando ,Arnaud Giese ,Institut Pasteur ,Noemie Djokovic ,Schwierige Zeiten ,Matthew Cole Jessica Hodgson ,Preclinical Development ,Group Leader Animal Pharmacology Platform ,Vector Development Platform For Inner Ear Disorders ,Association For Research ,International Media Relations ,Consilium Strategic Communications ,Regulatory News ,Annual Midwinter Meeting ,Preclinical Development Director ,Midwinter Meeting ,Winter Meeting ,Adeno Associated Vector Based Gene Therapy ,Autosomal Recessive Non Syndromic Deafness ,Inner Ear ,Crystal Ballroom ,Cisplatin Induced Ototoxicity ,Cochlear Limited ,Sudden Sensorineural Hearing Loss ,Strategic Communications ,Jessica Hodgson ,Sensorion ,Hill ,Present ,Posters ,Association ,Research ,Otolaryngology ,6th ,Nnual ,Midwinter ,Meeting ,